Delivery Order SPE2DB24D1205-SPE2DB25FCZPN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xcopri 100 mg tablets (30-count units) valued at $3,536.88. This is a firm fixed-price delivery order with no set-aside designation, classified as a competitive award. The contract has an ultimate completion date of August 11, 2025, and performance will be executed at AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,569.42 on July 28, 2025, for Xcopri 50 mg tablets (30-count supply). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract under the company's existing pharmaceutical supply agreements with DLA. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Xcopri 100 mg tablets (30-count packaging) valued at $1,037.97. This firm fixed-price delivery order, with an ultimate completion date of August 18, 2025, represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,357.92 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Xcopri 25 mg tablets (30-count). This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 6, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The contract involves no set-aside designation and identifies Conshohocken, Pennsylvania, as the place of performance,...
- The Defense Logistics Agency awarded a delivery order valued at $1,624.86 to AmerisourceBergen Drug Corp for 30 tablets of Xcopri 200 mg, with an ultimate completion date of August 13, 2025. This competitive award, issued on August 12, 2025, employs firm fixed pricing and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xcopri 100 mg tablets in quantities of 30 units, with a ceiling value of $2,357.92 and an ultimate completion date of August 11, 2025. This competitively awarded, non-set-aside contract utilized firm fixed price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Xcopri 25 mg tablets (30-unit packaging), with a contract ceiling value of $1,768.44. This is a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $3,660.38 to AmerisourceBergen Drug Corp for 30 tablets of Xcopri 100 mg on August 11, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $4,330.58 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Xcopri 50 mg tablets (30-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1.9K to AmerisourceBergen Drug Corp for Xcopri 200 mg tablets (30-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by August 13, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery from its corporate office location in the same municipality. This delivery...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZPNDelivery Order
The Defense Logistics Agency awarded a $3,017.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Xcopri 200 mg tablets (30-count units). The award is non-competitive with no set-aside designation and carries an ultimate completion date of August 18, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical procurement contracts predominantly with the Defense Logistics Agency and its Medical Supply Chain, demonstrating significant capability in fulfilling defense health system pharmaceutical requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/15/25 |